The mission of the Clinical Trials Office (CTO) Shared Resource is to provide a supportive environment for the successful conduct of clinical trials in order to facilitate and promote clinical research within the UCSD Cancer Center. One of the fundamental activities of a cancer center is the translation of novel scientific information into new treatments for patients with cancer. This cannot be accomplished without an efficiently functioning infrastructure to support the clinical investigator in this endeavor. CTO services are provided to all principal investigators within the Cancer Center as evidence of value added for membership. It provides centralized administrative and management support for all clinical trials at every stage of development from inception to completion. Services include: (1) Assistance with protocol preparation. We have developed a CTO Handbook that provides specific instructions for protocol preparation and which is also a complete guide to protocol management; (2) Assistance in protocol preparation for submission to the UCSD Protocol Review Monitoring Committee as well as the Institutional Review Board. We assist in the preparation of the IRB application and protocol consent form; (3) Assistance in the preparation of the protocol for submission to outside regulatory bodies (e.g. FDA) and/or pharmaceutical companies; (4) Assistance in budget preparation for submission to extramural funding entities; (5) Following activation of a protocol, we provide complete CRA and data management support; (6) Assist in the identification of potential patients of all protocols that we manage; (7) Wide dissemination of information of information regarding active protocols to internal and other physicians through the use of printed and electronic media. We have developed and published a """"""""Protocol Handbook) that is provided to all investigators. Additionally, we participate in the maintenance of the UCSD Cancer Center Web Site wherein information on all protocols is provided. As evidence of the importance of this infrastructure, much of it implemented since 1998, we have increased the number of UCSD sponsored clinical trials by 30%, and have increased our accrual to clinical trials to 230% of the previous levels. Continued efforts are underway to further increase both the number of active trials and accrual through recruitment of faculty with established track records in clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023100-19
Application #
6599267
Study Section
Project Start
2002-06-11
Project End
2003-04-30
Budget Start
Budget End
Support Year
19
Fiscal Year
2002
Total Cost
$183,723
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Jiang, Qingfei; Jamieson, Catriona (2018) BET'ing on Dual JAK/BET Inhibition as a Therapeutic Strategy for Myeloproliferative Neoplasms. Cancer Cell 33:3-5
Ramirez, Oscar; Aristizabal, Paula; Zaidi, Alia et al. (2018) Implementing a Childhood Cancer Outcomes Surveillance System Within a Population-Based Cancer Registry. J Glob Oncol :1-11
Liu, Liang; Yang, Lin; Yan, Wei et al. (2018) Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis. Clin Cancer Res 24:2370-2382
Lwin, Thinzar M; Murakami, Takashi; Miyake, Kentaro et al. (2018) Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore. Ann Surg Oncol 25:1079-1085
Singh, Siddharth; Loomba, Rohit (2018) Role of two-dimensional shear wave elastography in the assessment of chronic liver diseases. Hepatology 67:13-15
Hartman, Sheri J; Nelson, Sandahl H; Myers, Emily et al. (2018) Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study. Cancer 124:192-202
Hoffmann, Hanne M; Gong, Ping; Tamrazian, Anika et al. (2018) Transcriptional interaction between cFOS and the homeodomain-binding transcription factor VAX1 on the GnRH promoter controls Gnrh1 expression levels in a GnRH neuron maturation specific manner. Mol Cell Endocrinol 461:143-154
Liu, Xuxiang; Cao, Minghui; Palomares, Melanie et al. (2018) Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts. Breast Cancer Res 20:127
Huang, Justin K; Carlin, Daniel E; Yu, Michael Ku et al. (2018) Systematic Evaluation of Molecular Networks for Discovery of Disease Genes. Cell Syst 6:484-495.e5
Kalyanaraman, Hema; Schwaerzer, Gerburg; Ramdani, Ghania et al. (2018) Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes. Diabetes 67:607-623

Showing the most recent 10 out of 862 publications